We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MJCO
7001
DELISTED
Majesco
MJCO
$0 ﹤0.01%
+31
New +$162
GSB
7002
DELISTED
GlobalSCAPE, Inc.
GSB
$0 ﹤0.01%
26
-53
-67% -$210
ROYT
7003
DELISTED
PACIFIC COAST OIL TRUST
ROYT
$0 ﹤0.01%
47
AVH
7004
DELISTED
AVIANCA HOLDINGS S.A.
AVH
-64
Closed -$1K
DERM
7005
CALL
DELISTED
Dermira, Inc.
DERM
-19,600
Closed -$594K
GNMX
7006
DELISTED
Aevi Genomic Medicine Inc
GNMX
$0 ﹤0.01%
310
+227
+273% +$1.03K
MDR
7007
PUT
DELISTED
McDermott International
MDR
-6,767
Closed -$150K
JAG
7008
DELISTED
Jagged Peak Energy Inc.
JAG
$0 ﹤0.01%
+4
New +$54
LKSD
7009
CALL
DELISTED
LSC Communications, Inc.
LKSD
-24
Closed -$1K
LKSD
7010
PUT
DELISTED
LSC Communications, Inc.
LKSD
-468
Closed -$14K
ANFI
7011
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$0 ﹤0.01%
10
ONCE
7012
CALL
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-900
Closed -$45K
NVTR
7013
DELISTED
Nuvectra Corporation Common Stock
NVTR
$0 ﹤0.01%
+69
New +$472
CVRS
7014
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$0 ﹤0.01%
283
-750
-73% -$611
ALDR
7015
CALL
DELISTED
Alder Biopharmaceuticals
ALDR
-45,000
Closed -$936K
VSM
7016
PUT
DELISTED
Versum Materials, Inc.
VSM
-1,400
Closed -$39K
DTV
7017
DELISTED
DTE Energy Company 2016 Corporate Units
DTV
-14,700
Closed -$779K
HLTH
7018
DELISTED
Nobilis Health Corp.
HLTH
$0 ﹤0.01%
+286
New +$595
NEE.PRR
7019
DELISTED
NextEra Energy, Inc.
NEE.PRR
-100,000
Closed -$4.9M
RYAM.PRA
7020
DELISTED
Rayonier Advanced Materials Inc. 8.00% Series A Mandatory Convertible Preferred Stock
RYAM.PRA
-25,000
Closed -$2.9M
HIVE
7021
DELISTED
Aerohive Networks
HIVE
$0 ﹤0.01%
215
-2,527
-92% -$12.7K
LGCY
7022
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$0 ﹤0.01%
+15
New +$34
INSY
7023
CALL
DELISTED
Insys Therapeutics, Inc.
INSY
-6,200
Closed -$57K
FRSH
7024
DELISTED
Papa Murphy's Holdings, Inc
FRSH
$0 ﹤0.01%
11
VISL
7025
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
0

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.